Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Journal of Biopharmaceutical Statistics
|
October 19, 2012
A Bayesian approach for PK/PD modeling with PD data below limit of quantification
Huafeng Zhou, Alan Hartford, Kuenhi Tsai
Pharmaceutical Statistics
|
April 5, 2017
Enabling robust assessment of QTc prolongation in early phase clinical trials
Devan V Mehrotra, Li Fan, Fang Liu, et al.
Journal of Biopharmaceutical Statistics
|
July 9, 2008
Clinical trials simulation: a statistical approach
Peter H Westfall, Kuenhi Tsai, Stephan Ogenstad, et al.
Protein Science : a Publication of the Protein Society
|
June 7, 2005
Investigation of protein refolding using a fractional factorial screen: a study of reagent effects and interactions
Melissa Swope Willis, James K Hogan, Prakash Prabhakar, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
November 1, 2019
Cardiac risk assessment based on early Phase I data and PK-QTc analysis is concordant with the outcome of thorough QTc trials: an assessment based on eleven drug candidates
Puneet Gaitonde, Yeamin Huh, Borje Darpo, et al.
The Journal of Allergy and Clinical Immunology
|
September 16, 2017
The effects of house dust mite sublingual immunotherapy tablet on immunologic biomarkers and nasal allergen challenge symptoms
Natasha C Gunawardana, Qing Zhao, Leonidas N Carayannopoulos, et al.
Clinical Pharmacology and Therapeutics
|
August 21, 2018
Clinical Evaluation of MK-2640: An Insulin Analog With Glucose-Responsive Properties
Alexander W Krug, Sandra A G Visser, Kuenhi Tsai, et al.
The AAPS Journal
|
August 28, 2014
A semi-mechanistic model for the effects of a novel glucagon receptor antagonist on glucagon and the interaction between glucose, glucagon, and insulin applied to adaptive phase II design
Joanna Z Peng, William S Denney, Bret J Musser, et al.
Clinical and Translational Science
|
July 28, 2017
Dopamine Transporter Neuroimaging as an Enrichment Biomarker in Early Parkinson's Disease Clinical Trials: A Disease Progression Modeling Analysis
Daniela J Conrado, Timothy Nicholas, Kuenhi Tsai, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 9, 2018
Brain Imaging of Alzheimer Dementia Patients and Elderly Controls with <sup>18</sup>F-MK-6240, a PET Tracer Targeting Neurofibrillary Tangles
Talakad G Lohith, Idriss Bennacef, Rik Vandenberghe, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Journal of Biopharmaceutical Statistics
|
October 19, 2012
A Bayesian approach for PK/PD modeling with PD data below limit of quantification
Huafeng Zhou, Alan Hartford, Kuenhi Tsai
Pharmaceutical Statistics
|
April 5, 2017
Enabling robust assessment of QTc prolongation in early phase clinical trials
Devan V Mehrotra, Li Fan, Fang Liu, et al.
Journal of Biopharmaceutical Statistics
|
July 9, 2008
Clinical trials simulation: a statistical approach
Peter H Westfall, Kuenhi Tsai, Stephan Ogenstad, et al.
Protein Science : a Publication of the Protein Society
|
June 7, 2005
Investigation of protein refolding using a fractional factorial screen: a study of reagent effects and interactions
Melissa Swope Willis, James K Hogan, Prakash Prabhakar, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
November 1, 2019
Cardiac risk assessment based on early Phase I data and PK-QTc analysis is concordant with the outcome of thorough QTc trials: an assessment based on eleven drug candidates
Puneet Gaitonde, Yeamin Huh, Borje Darpo, et al.
The Journal of Allergy and Clinical Immunology
|
September 16, 2017
The effects of house dust mite sublingual immunotherapy tablet on immunologic biomarkers and nasal allergen challenge symptoms
Natasha C Gunawardana, Qing Zhao, Leonidas N Carayannopoulos, et al.
Clinical Pharmacology and Therapeutics
|
August 21, 2018
Clinical Evaluation of MK-2640: An Insulin Analog With Glucose-Responsive Properties
Alexander W Krug, Sandra A G Visser, Kuenhi Tsai, et al.
The AAPS Journal
|
August 28, 2014
A semi-mechanistic model for the effects of a novel glucagon receptor antagonist on glucagon and the interaction between glucose, glucagon, and insulin applied to adaptive phase II design
Joanna Z Peng, William S Denney, Bret J Musser, et al.
Clinical and Translational Science
|
July 28, 2017
Dopamine Transporter Neuroimaging as an Enrichment Biomarker in Early Parkinson's Disease Clinical Trials: A Disease Progression Modeling Analysis
Daniela J Conrado, Timothy Nicholas, Kuenhi Tsai, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 9, 2018
Brain Imaging of Alzheimer Dementia Patients and Elderly Controls with <sup>18</sup>F-MK-6240, a PET Tracer Targeting Neurofibrillary Tangles
Talakad G Lohith, Idriss Bennacef, Rik Vandenberghe, et al.
Page
of 1